Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular disease
Diabetes & Vascular Disease Research · 2026-07 · 23 (4)
DOI: 10.1177/14791641261474099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Vascular Disease Research, online erschienen am 01.08.2026. Verfasst von Aya Shouma und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. Hauptthemen laut MEDLINE: Transcriptome, Diabetic Angiopathies, Gene Expression Profiling, Atherosclerosis. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: British Heart Foundation, The National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre.
Abstract (Originalsprache)
Diabetes mellitus (DM) approximately doubles the risk of atherosclerotic cardiovascular disease (ASCVD) events, but the molecular basis is poorly understood. Using RNA-sequencing data from two arterial sites in >90 people with DM and >330 controls, we defined differentially expressed genes (DEGs) associated with DM. UK Biobank (UKB) was then used to corroborate that DEGs in their plasma protein form were differentially abundant in people with DM and associated with ASCVD events. 619 and 356 DEGs were associated with DM in the thoracic aorta and tibial artery, respectively. Of these, 22 were common to both arteries, all of which were directionally concordant. Of these, 5 were included in the UKB plasma proteomics dataset and we corroborated 4 (ACP5, LEFTY2, LILRA5 and PSME2) as showing concordant differential abundance in people with DM; all were associated with a range of incident ASCVD events. Addition of the 4 proteins to the SCORE2 and SCORE2-Diabetes risk models (for people without and with DM, respectively) improved the population-level discrimination, classification and calibration of these models. These data show that DM is associated with a distinct arterial gene expression profile, hits from which are associated with ASCVD events and add value to risk prediction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
- Faculty of Medicine, Mansoura University, Mansoura, Egypt.
- Cardiometabolic Imaging, Baker Heart and Diabetes Institute, Melbourne, Australia.
- Medicine, University of Melbourne, Melbourne, Australia.
ORCID-Profile: Richard M Cubbon
Förderung
- British Heart Foundation
- The National Institute for Health and Care Research (NIHR) Leeds Biomedical Research Centre
Zitieren
APA
Shouma, A., Giannoudi, M., Conning-Rowland, M., Drozd, M., Brown, O. I., Cheng, C., Sukumar, P., Bridge, K. I., Levelt, E., Bailey, M. A., Griffin, K. J., Kearney, M. T., & Cubbon, R. M. (2026). Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular disease. Diabetes & Vascular Disease Research, 23(4). https://doi.org/10.1177/14791641261474099
Vancouver
Shouma A, Giannoudi M, Conning-Rowland M, Drozd M, Brown OI, Cheng C, et al. Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular disease. Diabetes & Vascular Disease Research. 2026;23(4). doi:10.1177/14791641261474099
BibTeX
@article{Shouma2026,
author = {Shouma, Aya and Giannoudi, Marilena and Conning-Rowland, Marcella and Drozd, Michael and Brown, Oliver I and Cheng, Chew and Sukumar, Piruthivi and Bridge, Katherine I and Levelt, Eylem and Bailey, Marc A and Griffin, Kathryn J and Kearney, Mark T and Cubbon, Richard M},
title = {Analysis of the diabetic arterial transcriptome to define novel biomarkers of macrovascular disease},
journal = {Diabetes & Vascular Disease Research},
year = {2026},
volume = {23},
number = {4},
doi = {10.1177/14791641261474099}
}
EUVIMED